Introduction {#s1}
============

Enterococci, gram-positive, facultative anaerobic bacteria, are among the most abundant commensal flora of the human and animal gut microbiomes (Shepard and Gilmore, [@B47]; Heidari et al., [@B17]). These microorganisms are of medical importance as opportunistic pathogens, especially in severely ill or immunocompromised hosts (Carmeli et al., [@B5]; da Silva et al., [@B8]). Of the medically important *Enterococcus* species, specifically *E. faecium* and *E. faecalis, E. faecium* causes emergent and challenging hospital-acquired infections due to its resistance to antibiotics (French, [@B14]; Shepard and Gilmore, [@B47]; Zirakzadeh and Patel, [@B57]; O\'Driscoll and Crank, [@B40]; Heidari et al., [@B18]). *E. faecium* is listed among the "ESKAPE" pathogens that are potentially drug resistant and can cause life-threatening nosocomial infections (Rice, [@B43]; Pendleton et al., [@B41]). Colonization and infection of vancomycin-resistant enterococci (VRE) has dramatically increased over a short period of time in many countries (O\'Driscoll and Crank, [@B40]). VRE has developed resistance to other classes of antibiotics, and VRE infections are more difficult to treat than other enterococcal infections because fewer therapeutic options, such as linezolid, daptomycin, and tigecycline, are available to kill these bacteria (Zirakzadeh and Patel, [@B57]; O\'Driscoll and Crank, [@B40]). In addition to antimicrobial resistance, enterococci harbor several virulence factors, including major autolysin (AtlA), enterococcal leucine-rich repeat-containing protein (ElrA), enterococcal surface protein (Esp), cytolysin (CylA), and collagen-binding protein (Acm), which lead to them being opportunistic pathogens (Shankar et al., [@B46]; Eckert et al., [@B10]; Emirian et al., [@B11]; Arias and Murray, [@B3]; Dumoulin et al., [@B9]; Hendrickx et al., [@B19]; Heidari et al., [@B17], [@B18]).

The production and secretion of outer membrane vesicles (OMVs) have been identified in many gram-negative pathogens (Kuehn and Kesty, [@B29]; Kulp and Kuehn, [@B30]). OMVs enhance bacterial pathogenesis by delivery of virulence factors to host cells, biofilm formation, increased antimicrobial resistance, and modulation of innate immune responses (Kuehn and Kesty, [@B29]; Kulp and Kuehn, [@B30]). Membrane vesicles (MVs) derived from gram-positive bacteria have been discovered in *Staphylococcus aureus, Bacillus* spp., *Clostridium* spp., and *Listeria monocytogenes* (Lee et al., [@B31], [@B32]; Rivera et al., [@B44]; Gurung et al., [@B16]; Nicholas et al., [@B39]). MVs derived from gram-positive pathogens are potent facilitators of host-pathogen interactions via transport of virulence factors and modulation of immune response, similar to OMVs from gram-negative pathogens (Rivera et al., [@B44]; Gurung et al., [@B16]; Thay et al., [@B49]; Nicholas et al., [@B39]). The biogenesis of bacterial extracellular vesicles is still poorly understood, but stressful environments such as growth temperature, envelope stress, or oxidizing agents have been shown to increase their production (Mug-Opstelten and Witholt, [@B37]; Katsui et al., [@B25]; Thompson et al., [@B50]; McBroom and Kuehn, [@B35]). Subinhibitory concentrations of gentamicin and polymyxin B increase the production of OMVs in gram-negative pathogens (Kadurugamuwa and Beveridge, [@B23]; Macdonald and Kuehn, [@B34]). Moreover, treatment of gram-positive bacteria with β-lactam antibiotics stimulates the production of MVs through a weakening of the cell walls (Biagini et al., [@B4]; Toyofuku et al., [@B51]; Yun et al., [@B56]; Andreoni et al., [@B2]). Thus, the extracellular vesicles produced by pathogens under antibiotic stress conditions that are often encountered during infection may interact with host cells differently than those produced by pathogens under no antibiotic conditions.

Clinical *E. faecium* isolates have been shown to produce MVs during *in vitro* culture (Wagner et al., [@B52]). Several virulence factors and antimicrobial resistance-related proteins were identified in *E. faecium* MVs, suggesting that *E. faecium* MVs may augment pathogenesis and antimicrobial resistance. However, the pathogenic attributes of *E. faecium* MVs toward host cells have yet to be determined. The aim of this study was to explore the production of MVs in *E. faecium* cultured with subinhibitory concentrations of different antibiotics and investigate the ability of these MVs to induce cytotoxicity and pro-inflammatory responses in colon epithelial cells.

Materials and Methods {#s2}
=====================

Bacterial Strains
-----------------

*E. faecium* ATCC 700221 obtained from the American Type Culture Collection (Manassas, VA, USA) was used in this study. Bacteria were grown in brain heart infusion (BHI) media (BD Biosciences, San Jose, CA, USA) at 37°C.

Cell Culture
------------

Caco-2 cells originating from a heterogeneous colorectal adenocarcinoma were purchased from the Korean Cell Line Bank (Seoul, Korea). Cells were grown in minimal essential medium (HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum (HyClone), 2 mM [l]{.smallcaps}-glutamine, 1,000 U/ml penicillin G, and 50 μg/ml streptomycin at 37°C in a humidified atmosphere with 5% CO~2~.

Antimicrobial Susceptibility Test
---------------------------------

The minimum inhibitory concentrations (MICs) of vancomycin and linezolid were determined by microdilution methods according to the Clinical Laboratory Standards Institute (Clinical Laboratory Standards Institute, [@B7]). *E. faecalis* ATCC 29212 and *S. aureus* ATCC 29213 were used as quality control strains.

Isolation of MVs
----------------

MVs produced by *E. faecium* ATCC 700221 were isolated from bacterial culture supernatants as previously described (Gurung et al., [@B16]; Kim et al., [@B28]; Yun et al., [@B56]). *E. faecium* was cultured in 500 ml of BHI broth at 37°C with shaking. Bacteria were cultured in 500 ml of BHI broth supplemented with 1/2 MIC of vancomycin (256 μg/ml) or linezolid (1 μg/ml) at 37°C with shaking to isolate MVs from *E. faecium* under antibiotic stress conditions. Bacteria were cultured to late exponential phase ([Figure S1](#SM1){ref-type="supplementary-material"}). Bacterial cells were centrifuged at 6,000g for 15 min at 4°C. The culture supernatants were filtered using a QuixStand Benchtop System (GE Healthcare, Amersham, UK) with a 0.2 μm hollow fiber membrane (GE Healthcare), and concentrated using a QuixStand Benchtop System with a 500 kDa hollow fiber membrane (GE Healthcare). MV samples were ultracentrifuged at 150,000g for 3 h at 4°C and washed in phosphate-buffered saline (PBS) followed by another ultracentrifugation cycle, after which MV pellets were resuspended in PBS. The protein concentrations of the MVs were measured using a modified BCA assay (Thermo Scientific, Waltham, MA, USA). Purified MVs were verified the sterility by streaking on blood agar plates and then stored at −80°C until use. *E. faecium* MVs were treated with proteinase K (0.1 μg/ml) (Biofact, Daejeon, Korea) for 3 h at 50°C for the degradation of MV proteins (Jeon et al., [@B20]).

Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-Page)
--------------------------------------------------------------------

Bacteria were cultured to reach late exponential phase and then disrupted by sonication (Branson Ultrasonics Corp., Danbury, CT, USA). Proteins in the culture supernatant were precipitated with 10% trichloroacetic acid. The bacterial lysate, culture supernatants, and MVs corresponding to 10 μg of protein were mixed with SDS-PAGE sample buffer (1 M Tris HCl \[pH 6.8\], 10% SDS, 1% bromophenol blue, glycerol, and β-mercaptoethanol) and boiled for 10 min. The samples were then separated on a 10% SDS-PAGE gel, and gels were stained with Coomassie brilliant blue R-250 (Bio-Rad, Hercules, CA, USA).

Transmission Electron Microscopic (TEM) Analysis
------------------------------------------------

Purified *E. faecium* MVs samples were applied onto copper grids and stained with 1 or 2% uranyl acetate. Samples were visualized using a transmission electron microscope (HT-7700, Hitachi, Japan) operating at 120 kV.

Identification of Proteins in *E. faecium* MVs
----------------------------------------------

Proteins in the MVs of *E. faecium* ATCC 700221 were identified using one-dimensional gel electrophoresis and liquid chromatography-tandem mass spectrometry (1-DE-LC-MS/MS) as previously described (Yun et al., [@B56]). Fifteen μg of MV proteins were separated on a 12% SDS-PAGE. The gel was fractionated eight fractions according to molecular weight. Tryptic in-gel digestion was performed as previously described (Choi et al., [@B6]). Digested peptides were dissolved in sample buffer (0.02% acetic acid and 0.1% formic acid). Peptides were loaded onto a 2G-V/V trap column (Waters, Milford, MA, USA). Peptides were directed onto a 10 cm × 75 μm (i.d.) C18 reversed-phase column at a flow rate of 300 nL/min. High performance liquid chromatography conditions and search parameters for tandem mass spectrometry (MS/MS) analysis were applied as described previously (Choi et al., [@B6]). All MS and MS/MS spectra obtained using the LTQ-Velos ESI ion trap mass spectrometer were acquired in the data-dependent mode. Nano-LC-MS/MS spectra were searched with MASCOT version 2.4 (Matrix Science, UK) using protein sequences from the genome of *E. faecium* ATCC 700221 as a reference. A proteomic analysis was performed three times for each MV sample. Only proteins identified in three experiments were analyzed. The locations of MV proteins were predicted using the subcellular location prediction program, CELLO version 2.5 (<http://cello.life.nctu.edu.tw/>), per reference locations in UniProt (<https://www.uniprot.org/>). Proteins in *E. faecium* MVs were classified based on Gene Ontology (GO) functions using the Blast2GO 5.2 program (<https://www.blast2go.com/>).

Cell Viability Tests
--------------------

The viability of Caco-2 cells was measured using the 3-\[4,5-dimethylthiazol-2-yl\]-2,5 diphenyltetrazolium bromide (MTT) assay (Abcam, Cambridge, UK). Cells were seeded at a concentration of 1.0 × 10^5^/well in a 24-well microplate. Caco-2 cells were treated with *E. faecium* MVs for 24 h and then cell growth was measured at 570 nm, after 2 h of incubation with the MTT reagent.

Flow Cytometric Analyses
------------------------

Caco-2 cells were seeded at a concentration of 2.5 × 10^5^ cells/ml in 6-well plates. After treatment with 20 μg/ml of *E. faecium* MVs for 24 h, cells were stained with fluorescein isothiocyanate (FITC)-conjugated annexin V and propidium iodide (PI) (BD Biosciences, San Jose, CA, USA). The samples were analyzed in a FACSCalibur flow cytometer (BD Biosciences) by plotting PI and annexin V fluorescent intensities. For each sample, 10,000 cells were acquired for data analysis.

Quantitative Real-Time Polymerase Chain Reaction (qPCR) of Pro-inflammatory Cytokine and Chemokine Genes
--------------------------------------------------------------------------------------------------------

The expression of genes encoding glyceraldehyde 3-phosphate dehydrogenase (GAPDH), interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein (MCP)-1 was assessed by qPCR as described previously (Jun et al., [@B21]; Nho et al., [@B38]). Caco-2 cells were seeded in 6-well plates and then treated with 1, 2, or 5 μg/ml of *E. faecium* MVs for 3 h. Total RNA was extracted using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). cDNA was synthesized by reverse transcription of 1 μg of total RNA using oligo dT primers and M-MLV reverse transcriptase (Enzynomics, Daejeon, Korea). Gene expression was quantified using TOPreal™ qPCR 2X PreMIX (SYBR Green with high ROX) (Enzynomics) with an ABI PRISM 7500 Real-Time System (Applied Biosystems, Foster city, CA, USA). Fold changes in gene expression were calculated using the comparative Ct method. The expression levels of genes were normalized to GAPDH expression levels. Each experiment was performed in triplicate.

Statistical Analysis
--------------------

Data were analyzed using R 3.3.4 (<https://www.r-project.org/>). The expression of genes was analyzed using one-way ANOVA with Dunnett\'s *post-hoc* test. Cell death and cytokine gene expression between intact MVs and proteinase K-treated MVs were analyzed using Student\'s *t*-test. Differences of *P* \< 0.05 were considered as statistically significant.

Results {#s3}
=======

MV Production in *E. faecium* ATCC 700221 Cultured With or Without Antibiotics
------------------------------------------------------------------------------

To determine whether *E. faecium* ATCC 700221 produced MVs, bacteria were cultured in BHI broth to late exponential phase ([Figure S1](#SM1){ref-type="supplementary-material"}) and MVs were isolated from the culture supernatant. TEM analysis showed that *E. faecium* produced spherical MVs sized ≤50 nm ([Figure 1A](#F1){ref-type="fig"}). SDS-PAGE analysis showed the different protein profiles among bacterial lysates, culture supernatant, and MVs ([Figure 1B](#F1){ref-type="fig"}). *E. faecium* ATCC 700221 were resistant to vancomycin (MIC 512 μg/ml), but susceptible to linezolid (MIC 2 μg/ml). *E. faecium* were cultured in BHI broth with 1/2 MIC of vancomycin (256 μg/ml) or linezolid (1 μg/ml), and MVs were isolated from the culture supernatants to determine the effect of subinhibitory concentrations of antibiotics on MV production and their protein profiles. *E. faecium* cultured with 1/2 MIC of vancomycin or linezolid produced 3.0 (197.0 ± 5.4 μg/L) and 1.5 (95.8 ± 3.9 μg/L) times more MV proteins than bacteria cultured in BHI broth without antibiotics (65.0 ± 3.2 μg/L), respectively ([Figure 1C](#F1){ref-type="fig"}). Moreover, SDS-PAGE analysis showed the different protein profiles among MVs of *E. faecium* cultured in BHI broth without antibiotics (MVs/BHI), with vancomycin (MVs/VAN), or with linezolid (MVs/LIN) ([Figure 1D](#F1){ref-type="fig"}). These results suggest that antibiotics modulate MV biogenesis of *E. faecium* ATCC 700221 at subinhibitory concentrations.

![Membrane vesicles (MVs) produced by *E. faecium* ATCC 700221 cultured with or without antibiotics. **(A)** Transmission electron micrographs of MVs from *E. faecium* cultured in BHI broth. **(B)** SDS-PAGE analysis of proteins obtained from bacterial lysates (lane 1), culture supernatant (lane 2), and MVs (lane 3). Bacteria were cultured in BHI broth to late exponential phase. Lane M, molecular weight marker. **(C)** Production of MVs from *E. faecium* cultured with or without antibiotics. MVs were isolated from *E. faecium* cultured in BHI broth (MVs/BHI), BHI broth with 256 μg/ml vancomycin (MVs/VAN), or BHI broth with 1 μg/ml linezolid (MVs/LIN). The protein concentration of MVs isolated from 1 L of bacterial culture was measured using a modified BCA assay. Data are presented as the mean ± SD of three independent experiments. ^\*\*^*P* \< 0.01 compared to MVs/BHI. **(D)** SDS-PAGE analysis of MV proteins. Lane M, molecular weight marker; 1, MVs/BHI; 2, MVs/VAN; 3, MVs/LIN. **(A,B,D)** represent one of three independent experiments.](fcimb-09-00295-g0001){#F1}

Proteomes of MVs of *E. faecium* ATCC 700221 Cultured With or Without Antibiotics
---------------------------------------------------------------------------------

A proteomic analysis was performed to identify proteins in *E. faecium* MVs. A total of 438 proteins were identified in MVs/BHI ([Table S1](#SM2){ref-type="supplementary-material"}). Of these 438 proteins, 265, 153, and 20 were identified to be located in the cytoplasm, membrane, and extracellular compartments, respectively ([Figure 2A](#F2){ref-type="fig"}). A total of 371 proteins in the MVs/BHI were classified by GO functions, but 67 proteins were not classified into any GO group. Translation-associated proteins (*n* = 42) were the most common ([Figure 2B](#F2){ref-type="fig"}). Next, to determine the effect of antibiotics on the protein profiles of *E. faecium* MVs, the proteomes of MVs/LIN and MVs/VAN were analyzed. A total of 461 and 513 proteins were identified in MVs/VAN and MVs/LIN, respectively ([Table S1](#SM2){ref-type="supplementary-material"}). A total of 301 proteins were commonly identified in all three *E. faecium* MVs, whereas 51, 56, and 76 proteins were specifically identified in MVs/BHI, MVs/VAN, and MVs/LIN, respectively ([Figure 2C](#F2){ref-type="fig"}). Cellular localization of MV proteins was similar among MVs/BHI, MVs/LIN, and MVs/VAN ([Figure S2](#SM1){ref-type="supplementary-material"}), but the prevalence of MV proteins belonging to GO functional groups was different for the three *E. faecium* MVs ([Figure S3](#SM1){ref-type="supplementary-material"}).

![Proteomic analysis of MVs produced by *E. faecium* ATCC 700221. MVs were isolated from *E. faecium* cultured in BHI broth (MVs/BHI), BHI broth with 256 μg/ml vancomycin (MVs/VAN), or BHI broth with 1 μg/ml linezolid (MVs/LIN). **(A,B)** A total of 438 proteins in the MVs/BHI were analyzed based on cellular localization **(A)** and Gene Ontology **(B)**. **(C)** A Venn diagram of proteins identified in the MVs/BHI, MVs/VAN, and MVs/LIN.](fcimb-09-00295-g0002){#F2}

*E. faecium* ATCC 700221 harbors a plasmid-mediated *vanA* cluster that is responsible for resistance to vancomycin. The proteins encoded by the *vanA* cluster, including VanA, VanH, VanR, VanS, VanX, and VanZ, and aminoglycoside-modifying enzyme AphA were identified in MVs/VAN ([Table 1](#T1){ref-type="table"}). Cadmium resistance protein CadD and tellurite resistance protein TelA were also identified in MVs/VAN. Putative virulence factors, including autolysin (AMQ96750.1), collagen-binding protein (AMQ98256.1), catabolite control protein A (AMQ97727.1), fibronectin-binding protein (AMQ97173.1), and pilus assembly protein (AMQ98642.1), were also associated with *E. faecium* MVs. However, the relative amounts of antimicrobial resistance- and virulence-associated proteins in *E. faecium* MVs varied according to bacterial culture conditions ([Table 1](#T1){ref-type="table"} and [Table S1](#SM2){ref-type="supplementary-material"}). These results suggest that subinhibitory concentrations of antibiotics modulate the proteomes of *E. faecium* MVs.

###### 

Identification of antimicrobial resistance-and virulence-associated proteins in *E. faecium* MVs.

  **Protein**   **Functional description**              **Protein ID**   **MVs/BHI**                          **MVs/VAN**   **MVs/LIN**
  ------------- --------------------------------------- ---------------- ------------------------------------ ------------- -------------
  VanA          D-alanyl-D-alanine dipeptidase          AMQ98821.1       O[^\*^](#TN1){ref-type="table-fn"}   O             O
  VanH          Alpha-keto acid dehydrogenase           AMQ98822.1       X                                    O             X
  VanR          PhoB family transcriptional regulator   AMQ98437.1       X                                    O             O
  VanS          Histidine kinase                        AMQ98824.1       O                                    O             O
  VanX          Peptidase M15                           AMQ98820.1       O                                    O             X
  VanZ          Protein vanZ                            AMQ98819.1       X                                    O             O
  AphA          Aminoglycoside phosphotransferase       AMQ98790.1       X                                    O             O
  EmrB          Multidrug transporter                   AMQ96422.1       X                                    O             X
  DhaS          TetR family transcriptional regulator   AMQ96225.1       X                                    O             O
  ErmB          SAM-dependent methyltransferase         AMQ98797.1       O                                    O             O
  CadD          Cadmium resistance protein              AMQ98688.1       X                                    O             X
  TelA          Tellurite resistance protein            AMQ96515.1       O                                    O             O
  ArpU          Autolysin                               AMQ96750.1       O                                    X             X
  SdrD          Collagen-binding protein                AMQ98256.1       O                                    X             O
  CcpA          Catabolite control protein A            AMQ97727.1       O                                    O             O
  PavA          Fibronectin-binding protein             AMQ97173.1       X                                    X             O
  \-            Pilus assembly protein                  AMQ98642.1       O                                    X             O

*O, presence of proteins; X, absence of proteins*.

Host Cell Cytotoxicity Against MVs of *E. faecium* Cultured With or Without Antibiotics
---------------------------------------------------------------------------------------

To determine whether MVs produced by *E. faecium* ATCC 700221 could induce cytotoxicity in human colon epithelial cells, Caco-2 cells were treated with *E. faecium* MVs (0.25--20 μg/ml protein) for 24 h, and the viability of cells was analyzed using an MTT assay. Cytotoxicity was observed in Caco-2 cells treated with ≥5 μg/ml of MVs/BHI and MVs/VAN and in Caco-2 cells treated with ≥0.5 μg/ml of MVs/LIN ([Figure 3A](#F3){ref-type="fig"}). Cytotoxicity was significantly different between MVs/BHI and MVs/LIN at ≥0.5 μg/ml, and between MVs/VAN and MVs/LIN at ≥2 μg/ml. Live bacteria at multiplicity of infection (MOI) 10 were more cytotoxic to Caco-2 cells than 5 μg/ml of MVs/BHI, but cytotoxic activity was similar between dead bacteria at MOI 100 and 5 μg/ml of MVs/BHI ([Figure S4](#SM1){ref-type="supplementary-material"}). When Caco-2 cells were treated with 256 μg/ml of vancomycin or 1 μg/ml of linezolid as a negative control, no cytotoxicity was observed. Cell death induced by *E. faecium* MVs was further analyzed with flow cytometry wherein Caco-2 cells were treated with 20 μg/ml of MVs/BHI, MVs/VAN, or MVs/LIN for 24 h. MVs/LIN were more cytotoxic to Caco-2 cells than MVs/BHI or MVs/VAN ([Figure 3B](#F3){ref-type="fig"}). These results suggest that *E. faecium* MVs contain factors that are cytotoxic to host cells, and that *E. faecium* exposed to subinhibitory concentrations of linezolid produces more cytotoxic MVs than under exposure to subinhibitory concentrations of vancomycin or no antibiotics.

![Cytotoxicity of Caco-2 cells treated with MVs from *E. faecium* ATCC 700221. MVs were isolated from culture supernatants of *E. faecium* cultured in BHI broth (MVs/BHI), BHI broth with 256 μg/ml vancomycin (MVs/VAN), or BHI broth with 1 μg/ml linezolid (MVs/LIN). Cells were treated with various concentrations of *E. faecium* MVs for 24 h. **(A)** Cell viability was determined using an MTT assay. Data are presented as the mean ± SD of three independent experiments. ^+^*P* \< 0.05, ^++^*P* \< 0.01 compared to untreated control cells. \**P* \< 0.05, \*\**P* \< 0.01 among the same concentrations of MVs/BHI, MVs/VAN, or MVs/LIN. **(B)** Flow cytometric analysis of Caco-2 cell death induced by *E. faecium* MVs. Cells were treated with 20 μg/ml of *E. faecium* MVs for 24 h. Cells were stained with FITC-Annexin V and propidium iodide, and 10^4^ cells were counted. The figure represents one of three independent experiments that yielded similar results.](fcimb-09-00295-g0003){#F3}

Pro-inflammatory Responses in Caco-2 Cells Treated With MVs of *E. faecium* Cultured With or Without Antibiotics
----------------------------------------------------------------------------------------------------------------

To determine whether *E. faecium* MVs could induce pro-inflammatory responses, Caco-2 cells were treated with 1, 2, or 5 μg/ml of MVs/BHI, MVs/VAN, or MVs/LIN for 3 h, and the expression of genes encoding pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, and chemokines such as IL-8 and MCP-1 was analyzed using qPCR. Cytotoxicity was not observed in Caco-2 cells treated with ≤5 μg/ml of *E. faecium* MVs for 3 h (data not shown). The expression of *IL-1*β, *IL-6, IL-8*, and *MCP-1* genes significantly increased in cells treated with ≥1 μg/ml of MVs/BHI ([Figure 4](#F4){ref-type="fig"}). However, MVs/BHI did not stimulate the expression of *TNF*-α in cells treated with ≤5 μg/ml. MVs/VAN stimulated the expression of all cytokine genes tested in cells treated with ≥1 μg/ml. MVs/LIN stimulated the expression of *IL-1*β, *IL-6*, and *IL-8* at ≤5 μg/ml, whereas MVs/LIN significantly down-regulated the expression of *TNF*-α in cells treated with 1 and 2 μg/ml of MVs/LIN. The expression levels of *IL-1*β, *IL-6*, and *TNF*-α genes were significantly increased in cells treated with MVs/VAN compared to levels in cells treated with MVs/BHI or MVs/LIN. However, MVs/VAN did not significantly increase the expression of *IL-8* and *MCP-1* genes in Caco-2 cells as compared to MVs/BHI and MVs/LIN, with the exception of *IL-8* and *MCP-1* in cells treated with 1 μg/ml of MVs/VAN. MVs/BHI (5 μg/ml) induced more *IL-8* gene expression than dead bacteria at MOI 10 and 100 and live bacteria at MOI 10 ([Figure S5](#SM1){ref-type="supplementary-material"}). Vancomycin (256 μg/ml) and linezolid (1 μg/ml) did not induce the expression of *IL-8* gene in Caco-2 cells. These results suggest that MVs/VAN induce stronger pro-inflammatory responses in Caco-2 cells than MVs/BHI and MVs/LIN.

![Expression of pro-inflammatory cytokine and chemokine genes in Caco-2 cells treated with MVs from *E. faecium* ATCC 700221. MVs were isolated from culture supernatants of *E. faecium* cultured in BHI broth (MVs/BHI), BHI broth with 256 μg/ml vancomycin (MVs/VAN), or BHI broth with 1 μg/ml linezolid (MVs/LIN). Cells were treated with various concentrations of *E. faecium* MVs for 3 h and gene expression was assessed via qPCR. Data are presented as the mean ± SD of three independent experiments. ^+^*P* \< 0.05, ^++^*P* \< 0.01 compared to untreated control cells. \**P* \< 0.05, \*\**P* \< 0.01 among the same concentrations of MVs/BHI, MVs/VAN, or MVs/LIN.](fcimb-09-00295-g0004){#F4}

Suppression of Pro-Inflammatory Responses to Proteinase K-Treated *E. faecium* MVs
----------------------------------------------------------------------------------

MVs isolated from *E. faecium* ATCC 700221 cultured under different antibiotic stress conditions exhibited different proteomes and host cell responses. To determine whether *E. faecium* MV proteins contributed to cytotoxicity and pro-inflammatory responses in host cells, MVs/BHI were treated with proteinase K and MV proteins were degraded. Most MV proteins were degraded, but some MV proteins were resistant to proteinase K ([Figure S6](#SM1){ref-type="supplementary-material"}). Caco-2 cells were incubated with either intact or proteinase K-treated MVs for 24 h. Cell death was not significantly different between intact MVs and proteinase K-treated MVs ([Figure 5A](#F5){ref-type="fig"}). These results suggest that non-protein molecules or proteinase K-resistant proteins in *E. faecium* MVs contributes to host cell cytotoxicity. Next, Caco-2 cells were incubated with intact or proteinase K-treated MVs for 3 h and the expression levels of two selected cytokine genes, *IL-1*β and *IL-8*, were analyzed using qPCR. Even though there were some differences in the expression levels of *IL-1*β between MV batches (as shown in [Figures 4](#F4){ref-type="fig"}, [5B](#F5){ref-type="fig"}), the expression of *IL-1*β and *IL-8* was significantly decreased in cells incubated with proteinase K-treated MVs compared to that in cells treated with intact MVs ([Figure 5B](#F5){ref-type="fig"}). These results suggest that proteinase K-degradable MV proteins contribute to pro-inflammatory responses in Caco-2 cells.

![Host cell responses to proteinase K (PK)-treated *E. faecium* MVs. **(A)** Caco-2 cells were incubated with intact or PK-treated MVs/BHI for 24 h and cell viability was determined using an MTT assay. Data are presented as the mean ± SD of three independent experiments. **(B)** Cells were incubated with intact or PK-treated MVs/BHI for 3 h and gene expression was assessed via qPCR. Data are presented as the mean ± SD of three independent experiments. \*\**P* \< 0.01 comparing intact and PK-treated MVs.](fcimb-09-00295-g0005){#F5}

Discussion {#s4}
==========

Antibiotics modulate bacterial physiology regarding bacterial growth, gene transcription, and toxin production at subinhibitory concentrations (Goh et al., [@B15]; Yim et al., [@B54]; Moura et al., [@B36]; Ramos et al., [@B42]; Sinel et al., [@B48]). This study demonstrates that antibiotics at subinhibitory concentrations can modulate the biogenesis and proteomes of MVs in *E. faecium*. Moreover, MVs produced by *E. faecium* cultured under different antibiotic stress conditions also induce different levels of cytotoxicity and pro-inflammatory responses in colon epithelial cells *in vitro*.

The production of MVs in *E. faecium* was first described in clinical isolates (Wagner et al., [@B52]). Four *E. faecium* strains produced spherical-shaped MVs, but MV size varied among strains. MVs derived from three of the *E. faecium* strains were similar in size at ≤50 nm in diameter, whereas MVs of *E. faecium* K59-68 were measured at an average of 83 nm in diameter. Proteins identified in *E. faecium* MVs also varied among strains and bacterial growth phases. MVs of *E. faecium* grown to stationary phase contained more diverse proteins than MVs of *E. faecium* grown to exponential phase. The number of proteins identified in the MVs of four clinical *E. faecium* strains cultured in BHI broth to exponential phase ranged from 162 to 605. In the present study, *E. faecium* ATCC 700221 produced spherical-shaped MVs with a size ≤50 nm. Different protein profiles were observed among bacterial lysates, culture supernatants, and MVs. A total of 438 proteins were identified in MVs/BHI of *E. faecium* ATCC 700221. Moreover, cytotoxicity and *IL-8* gene expression in host cells were different between dead bacteria and *E. faecium* MVs. These results suggest that *E. faecium* MVs are not dead bacterial cells or bacterial debris, but a specific nanocomplex that carries specific proteins and other molecules derived from bacteria. Furthermore, MV size and proteome differ among *E. faecium* strains.

MVs isolated from *E. faecium* cultured under antibiotic stress conditions contained a more diverse array of proteins than MVs from *E. faecium* cultured without antibiotics. Moreover, *E. faecium* produced more MVs under vancomycin stress condition than under linezolid stress condition, whereas the number of MV proteins was more diverse under linezolid stress condition than under vancomycin stress condition. Reductions in peptidoglycan cross-linking have been shown to increase MV production in *S. aureus* (Wang et al., [@B53]). Vancomycin inhibits cross-linking of *N*-acetylmuramic acid with *N*-acetylglucosamine. Subinhibitory concentrations of vancomycin may thus result in a loosening of peptidoglycan layers leading to increased MV production in *E. faecium*. *E. faecium* MVs contained a diverse array of proteins that localized to the membrane, cytosol, and extracellular compartments, with a high abundance of ribosomal proteins. This recapitulates data from previous studies on MVs derived from other gram-positive bacteria (Lee et al., [@B31], [@B32]; Gurung et al., [@B16]; Nicholas et al., [@B39]). However, the composition and relative amounts of proteins varied among MVs/BHI, MVs/VAN, and MVs/LIN. While linezolid blocks the initiation of protein synthesis, the number of proteins in MVs/LIN was the highest of all three *E. faecium* MVs. Although both vancomycin and linezolid are bactericidal toward *E. faecium*, why they modulate bacterial transcription and translation profiles in different ways remains to be investigated. Virulence factors such as collagen-binding protein (SdrD), CcpA, fibronectin-binding protein (PavA), and pilus assembly protein were associated with MVs/LIN, whereas proteins of the *vanA* cluster, the aminoglycoside-modifying enzyme AphA, the ribosome methylase ErmB, and transport proteins were found in MVs/VAN. In a previous study, the virulence factors Acm, CapD, Fnm, PilA2, PrpA, PtsD, and Scm, associated with bacterial adherence and colonization, AtlA, Esp, and SagA associated with biofilm formation, and CcpA associated with bacterial growth were identified in *E. faecium* MVs, but their associations therein differed among bacterial strains and growth phases (Wagner et al., [@B52]). The present study identified autolysin ArpU, CcpA, SdrD, PavA, and pilus assembly protein in *E. faecium* ATCC 700221 MVs. However, their association with MVs varied among MVs/BHI, MVs/LIN, and MVs/VAN. Antibiotics can activate or repress gene transcription and modulate MV biogenesis in bacteria at subinhibitory concentrations. This phenomenon may result in differences in protein components, including virulence factors, and antimicrobial resistance-associated proteins, between MVs/VAN and MVs/LIN.

*E. faecium* MVs induced host cell cytotoxicity in a dose-dependent manner. MVs/LIN showed the highest cytotoxic activity toward Caco-2 cells among the three *E. faecium* MVs. Lipoteichoic acid, extracellular superoxide anion, gelatinase, hyaluronidase, and cytolysin in *E. faecalis* or *E. faecium* contribute to tissue damage in the hosts (Kayaoglu and Ørstavik, [@B26]; Fisher and Phillips, [@B12]; Arias and Murray, [@B3]). However, these cytotoxic factors were not identified in *E. faecium* MVs in the present study. Moreover, no significant differences in host cell cytotoxicity were shown between intact and proteinase K-treated MVs, suggesting that non-protein components and/or proteinase K-resistant proteins in *E. faecium* MVs are responsible for this cytotoxicity, even though our previous study demonstrated that proteins associated with *S. aureus* MVs played a role in host cell cytotoxicity (Jeon et al., [@B20]). Further, α-hemolysin associated with *S. aureus* MVs was found to contribute to host cell cytotoxicity (Thay et al., [@B49]). Although the specific cytotoxic factors associated with *E. faecium* MVs were not determined in the present study, MVs produced by *E. faecium* cultured with subinhibitory concentrations of linezolid were highly cytotoxic.

MVs derived from gram-positive bacteria contain many pathogen-associated molecular patterns (PAMPs), such as membrane and cytoplasmic proteins, flagellins, peptidoglycans, and DNA (Lee et al., [@B31]; Jun et al., [@B22]; Liu et al., [@B33]). These bacterial ligands in the MVs may interact with specific receptors on host cells and thereby induce inflammatory responses. Our previous study showed that *S. aureus* MVs stimulated the expression of *IL-1*β, *IL-6, IL-8*, and *MIP-1*α genes in keratinocytes (Jun et al., [@B22]). Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 have been associated with peptidoglycans in *S. aureus* MVs and are implicated in the signaling pathways of inflammatory responses (Jun et al., [@B22]). In the present study, *E. faecium* MVs stimulated the expression of pro-inflammatory cytokine genes *IL-1*β and *IL-6* and chemokine genes *IL-8* and *MCP-1* in Caco-2 cells similarly to *S. aureus* MVs. However, proteinase K-treated *E. faecium* MVs significantly suppressed the expression of these cytokine genes as compared to intact MVs, suggesting that protein components in *E. faecium* MVs are largely responsible for pro-inflammatory responses in Caco-2 cells, unlike *S. aureus* MVs. An alternative explanation is that the degradation of surface proteins by proteinase K could have indirectly modulated other surface components. Because proteinase K-treated *E. faecium* MVs did not completely suppress the expression of these cytokine genes, it is possible that non-protein components such as peptidoglycans or proteinase K-resistant proteins of *E. faecium* MVs are also associated with pro-inflammatory responses in the host cells.

The expression of pro-inflammatory cytokine genes *IL-1*β, *IL-6*, and *TNF*-α was at the highest level in cells treated with MVs/VAN, whereas the expression of *MCP-1* gene was at the highest level in cells treated with MVs/BHI. These results suggest that antibiotics modulate the association of PAMPs with *E. faecium* MVs, which, in turn, influence pro-inflammatory responses in host cells. Further studies are required to identify specific PAMPs in *E. faecium* MVs and elucidate the signaling pathways associated with these pro-inflammatory responses.

Antibiotics affected the clinical outcomes of patients with *E. faecalis* bacteremia (Foo et al., [@B13]). Of the patients who treated with β-lactams or glycopeptides, glycopeptide therapy increased mortality of the patients with *E. faecalis* bacteremia (Foo et al., [@B13]). Several reports also demonstrated that glycopeptides rather than β-lactams were associated with increased patient treatment failure and mortality (Kim et al., [@B27]; Schweizer et al., [@B45]). Moreover, subinhibitory concentrations of antibiotics increase biofilm formation in multiple bacterial species, including *E. faecalis* (Kaplan, [@B24]; Andersson and Hughes, [@B1]; Yu et al., [@B55]). In the present study, subinhibitory concentrations of vancomycin enhanced the production of MVs in *E. faecium*. MVs produced by *E. faecium* cultured with subinhibitory concentrations of vancomycin induced stronger pro-inflammatory responses than MVs produced by *E. faecium* with subinhibitory concentrations of linezolid *in vitro*. The possible association of *E. faecium* MVs with bacterial pathogenesis and the clinical courses of infected patients treated with different antibiotics should be studied in greater depth in the future.

This study demonstrates that subinhibitory concentrations of antibiotics modulate MV-mediated host cell pathology in ways that are distinct from their antibacterial effects. The production of MVs in *E. faecium* under antibiotic stress conditions and the pathologic effects thereof on host cells help improve our understanding of the functional importance of bacterial extracellular vesicles.
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